The U.S. Department of health and human services (HHS), national institutes of health (NIH), national cancer institute (NCI), division of cancer epidemiology and genetics (DCEG), infections and…

Ended Purchase Order Awarded Last action

Contract number
75N91023P00223
Awardee
Awarding agency
Obligated
$397,800

Award facts

Opportunity
  • 75N91023Q00018 Solicitation number
Contract value 100% obligated
$397,800.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 $217,800
Original award $180,000

About this award

The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Infections and Immunoepidemiology Branch (IIB) awarded a $397,800.00 firm fixed-price purchase order contract to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization and foundation based in Germany. The contract, which does not have a set-aside designation, is for the testing of various elements related to cancer research. DKFZ has significant expertise in areas such as molecular pathogenesis, diagnostic approaches, and therapeutic developments, particularly in hereditary colorectal cancer and immunoprevention. The organization has a history of providing specialized services to U.S. federal agencies, including multiplex serology testing, data collection and management, and research on the relationship between infections and specific types of cancer. This contract award is the latest in a series of both prime and subcontract awards, as well as federal grant funding, that DKFZ has received from various HHS and Department of Defense components to support its cancer research initiatives.

Description

The U.S. Department of health and human services (HHS), national institutes of health (NIH), national cancer institute (NCI), division of cancer epidemiology and genetics (DCEG), infections and immunoepidemiology branch (IIB) requires the testing of

Quick answers

Who was awarded contract 75N91023P00223?

75N91023P00223 was awarded to Deutsches Krebsforschungszentrum by National Cancer Institute (National Institutes of Health) on March 6, 2023.

How much is contract 75N91023P00223 worth?

The government has obligated $397,800 on 75N91023P00223.

Was contract 75N91023P00223 competed?

The extent of competition for 75N91023P00223 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award